BMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price
Neurogene (NASDAQ:NGNE – Get Free Report) had its target price lowered by equities researchers at BMO Capital Markets from $45.00 to $16.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 40.85% from the […]
Neurogene (NASDAQ:NGNE – Get Free Report) had its target price lowered by equities researchers at BMO Capital Markets from $45.00 to $16.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 40.85% from the […]
